Drugs / B55R2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07230184 | Apr 2022 → Aug 2023 | diabetic retinopathy | AJU Pharm Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | B55R2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07230184 ↗ |
| Route | Oral | “orally twice daily” NCT07230184 ↗ |